Skip to Content

Richard Failor_7 (2)

Alan Failor, M.D.

Metabolism, Endocrinology and Nutrition

Clinical Professor of Medicine


Dr. Failor specializes in Endocrinology focusing on Diabetes, Diabetes care and Pituitary Disorders.


Parker, L., Failor, A., Weidman, K.:  Conditioned preferences in the rat with an unnatural need state:  morphine withdrawal.  J. Comp. Physiol. Psychol. 82:294-300, 1973

Li, H. C., Katz, A.M., Rephe, D.I., Failor, A.:  Oxalate dependence of calcium uptake kinetics of rabbit skeletal muscle microsomes (fragmented sarcoplasmic reticulum).  Biochim. Biophys. Acta 367:385-389, 1974

Glass, R.I.M., Mirel, R., Hollander, G., Kirchoff, L.R., Karlin, R., Failor, A.:  Screening for hypertension in the Emergency Department. JAMA 240:1973-1974, 1978

Foster, D.M., Chait, A., Albers, J.J., Failor, R.A., Harris, C., and Brunzell, J.D.:  Evidence for kinetic heterogeneity among human low density lipoproteins.  Metabolism 34:685-696, 1986

Chait, A., Foster, D.M., Albers, J.J., Failor, R.A., Harris, C., and Brunzell, J.D.:  Low density lipoprotein metabolism I familial combined hyperlipidemia and familial hypercholesterolemia: Kinetic analysis using an integrated model.  Metabolism 35:697-704, 1986

Childs, M.T., Dorsett, C., Failor, A., Roidt, C., and Omenn, G.:  Effect of shellfish consumption on cholesterol absorption in normolipidemic men.  Metabolism 36:31-35, 1987

Failor, R.A., Hokanson, J.E., and Brunzell, J.D.:  Low density lipoproteins in familial hyperlipidemias.  In: Atherosclerosis VII  (N.H. Fridge and P. Nestel, eds.). New York: Springer-Verlag, Excerpta medica, 1986, pg. 159-163

Deeb, S., Failor, A., Brown, B.G., Brunzell, J.D., Albers, J.J., Motulsky, A.G.:  Molecular genetics of apolipoproteins and coronary heart disease.  Gold Spring Harbor Symposium of Quantitative Biology LI; 403-404, 1986

Brunzell, J.D., Chait, A., Albers, J.J., Foster, D.M., Failor, R.A., Bierman, E.L.:  Metabolic consequences of genetic heterogeneity of lipoprotein composition. Am. Heart J. 113:593-598, 1987

Marzetta, C.A., Foster, D.M., Hokanson, J.E., Failor, R.A., Brunzell, J.D.:  Low density lipoprotein heterogeneity in familial combined hypertriglyceridemic states.  In Proceedings of the Workshop of Lipoprotein Heterogeneity.  NIH Publication No. 87-2646, pg. 285-292, 1987

Failor, R.A., Childs, M.T., Bierman, E.L.:  The effects of omega 3 and omega 6 fatty acid enriched diets upon plasma lipoproteins in subjects with familial combined hyperlipidemia.  Metabolism 37:1021-1028, 1988

Friday, K.E., Failor, R.A., Childs, M.T., Bierman, E.L.:  The effects of n-3 and n-6 fatty acid enriched diets on plasma lipoproteins and apolipoprotein s in heterozygous familial hypercholesterolemia.  Arterioscler. Thromb. 11:47-54, 1991

Deeb, SS, Failor, RA, Brown, BG, Brunzell, JD, Albers, JJ, Motulsky, AG, Wijsman, E. Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levels. Hum Genet  88:463-470, 1992.

Action to Control Cardiovascular Risk in Diabetes Study group, Gerstien HC, Miller ME, Byington RP, Goff DC Jr, Bigger JTT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probsfield JL, Simons- Morton DG, Friedewald WT. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med. 358:2545-2559, 2008.

Calles-Escandon J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, Bonds DE, Fonseca VA, Ismail-Beigi F, Banerji MA, Failor A, Hamilton B. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 33:721-727, 2010.